Research studies and recruitment

Please email OPA with requests for research recruitment listings - listing rate is $100 CAD for 1 year.

Request for Assistance with Research Participant Recruitment

Research Study Title: "The effects of DBT skills on long term BPD recovery"

To learn more, please contact Robyn Lam at rlam@adler.edu.

Robyn Lam, a Doctoral candidate in Clinical Psychology at Adler University, is conducting a research study on the long-term effects of Dialectical Behaviour Therapy (DBT) in women diagnosed with Borderline Personality Disorder (BPD). The study has received ethics approval from Adler University.

Clinicians are invited to refer patients who have completed, or are about to complete, a standard DBT program. The goal is to better understand how DBT skills training supports lasting improvements in daily life and wellbeing. Findings aim to inform and enhance therapeutic practices for women with BPD.

We are looking for participants who:

Are adult women (19 years of age or older)
Had an official primary diagnosis of BPD at the time of their DBT treatment
Live in Canada or the United States
Had completed one year of standard DBT program anytime in the past
Started the DBT program as adults (19 years of age or older)
Are able to give consent to joining the study
Are not currently in a standard DBT program
Have no current diagnoses of delirium, dementia, or psychosis

Participants will fill out an online survey about how they are doing now and how they use DBT skills. This will take about 30-45 minutes and can be done over a week. Their participation will be private, and they can leave the study anytime they want.

Exploring a potential new treatment for agitation in Alzheimer's disease

This is a study by CAMH, the leading mental health research hospital in Canada. Learn more about what's involved in participating in a study at CAMH Research Connect.

To learn more or ask about joining our study, please call 416-583-1350 or email scitad@camh.ca.

CAMH is part of an international study exploring a potential new treatment for agitation in people who have Alzheimer’s disease.

Treatment options for agitation in Alzheimer’s disease are limited. The S-CitAD study is a clinical trial sponsored by the National Institute on Aging (NIA) in the U.S. The study is examining if a prescription medication called escitalopram combined with psycho-social therapy can help reduce agitation. The therapy involves meeting with a trained health care professional and discussing activities, techniques and strategies that can help improve your well-being and day-to-day functioning.

First Name*
Last Name*
Company*
Email:*